TrialEuropean heart journal2014

Clinical characteristics and outcomes with rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation but underlying native mitral and aortic valve disease participating in the ROCKET AF trial.

Günter Breithardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.